CMV-specific donor-derived T lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CMV-specific donor-derived T lymphocytes, covering 2025-06-11 to 2025-06-11. Get the full timeline:
Most recent: Clinical Trial Update: CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency [NA]